Diabetes Pill's Real-World impact tracked in major hungarian study
NCT ID NCT06269120
Summary
This study follows 470 adults in Hungary with type 2 diabetes who are starting a pill called oral semaglutide as part of their regular doctor's care. Researchers will track changes in blood sugar control and body weight over about 6 months to see how well the treatment works in everyday practice. The study does not test a new drug but observes patients already prescribed this medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Siklósi Kórház, Diabetológia
RECRUITINGSiklós, 7801, Hungary
Conditions
Explore the condition pages connected to this study.